No abstract available
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Drug Therapy, Combination
-
Gastric Acid / metabolism
-
Gastric Mucosa / drug effects*
-
Gastric Mucosa / metabolism
-
Gastrointestinal Diseases / diagnosis
-
Gastrointestinal Diseases / drug therapy*
-
Gastrointestinal Diseases / physiopathology
-
Gastrointestinal Hemorrhage / diagnosis
-
Gastrointestinal Hemorrhage / prevention & control*
-
Helicobacter Infections / diagnosis
-
Helicobacter Infections / drug therapy*
-
Helicobacter Infections / microbiology
-
Helicobacter pylori / drug effects*
-
Hemostasis, Endoscopic
-
Humans
-
Hydrogen-Ion Concentration
-
Proton Pump Inhibitors / adverse effects
-
Proton Pump Inhibitors / pharmacokinetics
-
Proton Pump Inhibitors / therapeutic use*
-
Pyrroles / adverse effects
-
Pyrroles / pharmacokinetics
-
Pyrroles / therapeutic use*
-
Sulfonamides / adverse effects
-
Sulfonamides / pharmacokinetics
-
Sulfonamides / therapeutic use*
-
Treatment Outcome
Substances
-
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
-
Anti-Bacterial Agents
-
Proton Pump Inhibitors
-
Pyrroles
-
Sulfonamides